Aesynt Reports 80 New IV Automation Contracts, Including 62 Robots and 18 Software Solutions, in First Six Months Since Acquisition of Heath Robotics
“We are thrilled with the first six months of success in the IV automation space, which underscores the tremendous need to help hospitals and health systems find safe, efficient and cost-effective solutions to automate the highest risk area of the pharmacy”
CRANBERRY TOWNSHIP, Pa.--Aesynt, a leading provider of integrated pharmacy automation solutions for hospitals and health systems, announced today it has secured 80 new contracts for IV automation solutions, including 62 robots and 18 software solutions, in the six months since its acquisition of Health Robotics. Leading U.S. healthcare institutions such as Barnes Jewish Healthcare, Children's Healthcare of Atlanta, Restore Health and San Francisco General Hospital, as well as University Hospital in Brussels, Belgium, have chosen Aesynt solutions to automate processes and enhance workflow for compounding and dispensing intravenous medications. The company also has partnered with PharmaTech® in the Gulf Cooperation Council (GCC) Arab States and Supreme Products Co., Ltd. in Thailand as exclusive distributors in these countries.
"We are thrilled with the first six months of success in the IV automation space, which underscores the tremendous need to help hospitals and health systems find safe, efficient and cost-effective solutions to automate the highest risk area of the pharmacy," said Kraig McEwen, CEO of Aesynt. "We look forward to continued expansion as we execute our vision to automate processes, enhance workflow and reduce errors while improving safety."
The manual compounding and dispensing of injectable medications is one of the highest risk, expensive and labor-intensive processes in the hospital pharmacy. By adopting IV automation solutions, these hospitals are able to:
*Implement safe and efficient production of ready-to-administer IVs;
*Reduce medication errors;
*Increase medication throughput; and
*Lower costs associated with IV compounding and dispensing.
With the acquisition of Health Robotics, the leading global provider of IV automation solutions, Aesynt is now the only company to offer automation solutions at every stage of medication delivery—providing transparency into how hospitals and health systems buy, store, package, compound, track and deliver all types of medications. Through this comprehensive approach to pharmacy automation, Aesynt helps these organizations reduce costs, increase efficiency and have more time for patient care.
Aesynt Incorporated is committed to continuously advancing medication management, offering integrated pharmacy automation solutions that help health systems to support improved patient outcomes, build stronger businesses and manage ongoing change. For more information, visit www.aesynt.com. Follow Aesynt on Twitter at https://twitter.com/aesynt.